nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—RAF1—malignant glioma	0.116	0.159	CbGaD
Regorafenib—FGFR1—malignant glioma	0.114	0.157	CbGaD
Regorafenib—FLT1—malignant glioma	0.109	0.15	CbGaD
Regorafenib—NTRK1—malignant glioma	0.106	0.146	CbGaD
Regorafenib—PDGFRA—malignant glioma	0.0876	0.121	CbGaD
Regorafenib—BRAF—malignant glioma	0.0801	0.11	CbGaD
Regorafenib—KDR—malignant glioma	0.0681	0.0938	CbGaD
Regorafenib—CYP2B6—malignant glioma	0.0463	0.0638	CbGaD
Regorafenib—FGFR2—skull—malignant glioma	0.00291	0.0419	CbGeAlD
Regorafenib—FLT1—umbilical vein—malignant glioma	0.00255	0.0367	CbGeAlD
Regorafenib—KDR—umbilical vein—malignant glioma	0.00216	0.0311	CbGeAlD
Regorafenib—Traumatic liver injury—Temozolomide—malignant glioma	0.00205	0.0587	CcSEcCtD
Regorafenib—FLT4—endothelium—malignant glioma	0.00156	0.0224	CbGeAlD
Regorafenib—Lymphopenia—Temozolomide—malignant glioma	0.00149	0.0427	CcSEcCtD
Regorafenib—FLT4—blood vessel—malignant glioma	0.00143	0.0207	CbGeAlD
Regorafenib—TEK—endothelium—malignant glioma	0.00125	0.018	CbGeAlD
Regorafenib—DDR2—retina—malignant glioma	0.00124	0.0179	CbGeAlD
Regorafenib—FLT1—endothelium—malignant glioma	0.00121	0.0174	CbGeAlD
Regorafenib—EPHA2—blood vessel—malignant glioma	0.00118	0.017	CbGeAlD
Regorafenib—Cyst—Carmustine—malignant glioma	0.00118	0.0339	CcSEcCtD
Regorafenib—TEK—blood vessel—malignant glioma	0.00115	0.0166	CbGeAlD
Regorafenib—FLT1—blood vessel—malignant glioma	0.00112	0.0161	CbGeAlD
Regorafenib—NTRK1—midbrain—malignant glioma	0.0011	0.0159	CbGeAlD
Regorafenib—MAPK11—telencephalon—malignant glioma	0.00108	0.0156	CbGeAlD
Regorafenib—Sorafenib—RAF1—malignant glioma	0.00105	0.186	CrCbGaD
Regorafenib—Sorafenib—FGFR1—malignant glioma	0.00103	0.183	CrCbGaD
Regorafenib—Hepatotoxicity—Carmustine—malignant glioma	0.00102	0.0293	CcSEcCtD
Regorafenib—KDR—endothelium—malignant glioma	0.00102	0.0147	CbGeAlD
Regorafenib—Hepatotoxicity—Temozolomide—malignant glioma	0.000989	0.0283	CcSEcCtD
Regorafenib—Sorafenib—FLT1—malignant glioma	0.000987	0.175	CrCbGaD
Regorafenib—KDR—blood vessel—malignant glioma	0.000943	0.0136	CbGeAlD
Regorafenib—Endocrine disorder—Temozolomide—malignant glioma	0.000922	0.0264	CcSEcCtD
Regorafenib—Liver injury—Temozolomide—malignant glioma	0.000908	0.026	CcSEcCtD
Regorafenib—KIT—endothelium—malignant glioma	0.000906	0.013	CbGeAlD
Regorafenib—FLT4—embryo—malignant glioma	0.000856	0.0123	CbGeAlD
Regorafenib—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00084	0.024	CcSEcCtD
Regorafenib—EPHX2—retina—malignant glioma	0.000839	0.0121	CbGeAlD
Regorafenib—KIT—blood vessel—malignant glioma	0.000836	0.012	CbGeAlD
Regorafenib—PDGFRB—blood vessel—malignant glioma	0.000816	0.0117	CbGeAlD
Regorafenib—DDR2—spinal cord—malignant glioma	0.0008	0.0115	CbGeAlD
Regorafenib—Sorafenib—PDGFRA—malignant glioma	0.000795	0.141	CrCbGaD
Regorafenib—RET—embryo—malignant glioma	0.000756	0.0109	CbGeAlD
Regorafenib—Sorafenib—BRAF—malignant glioma	0.000728	0.129	CrCbGaD
Regorafenib—FGFR2—embryo—malignant glioma	0.000718	0.0103	CbGeAlD
Regorafenib—Neoplasm—Carmustine—malignant glioma	0.000715	0.0205	CcSEcCtD
Regorafenib—Neoplasm—Temozolomide—malignant glioma	0.000691	0.0198	CcSEcCtD
Regorafenib—TEK—embryo—malignant glioma	0.000688	0.00991	CbGeAlD
Regorafenib—FGFR1—telencephalon—malignant glioma	0.000687	0.00988	CbGeAlD
Regorafenib—FLT1—embryo—malignant glioma	0.000665	0.00958	CbGeAlD
Regorafenib—RAF1—embryo—malignant glioma	0.000662	0.00952	CbGeAlD
Regorafenib—FGFR2—brainstem—malignant glioma	0.000658	0.00947	CbGeAlD
Regorafenib—DDR2—central nervous system—malignant glioma	0.000649	0.00935	CbGeAlD
Regorafenib—DDR2—cerebellum—malignant glioma	0.000635	0.00914	CbGeAlD
Regorafenib—Gastroenteritis—Temozolomide—malignant glioma	0.000626	0.0179	CcSEcCtD
Regorafenib—PDGFRA—embryo—malignant glioma	0.000624	0.00898	CbGeAlD
Regorafenib—Sorafenib—KDR—malignant glioma	0.000619	0.11	CrCbGaD
Regorafenib—MAPK11—central nervous system—malignant glioma	0.000616	0.00886	CbGeAlD
Regorafenib—RAF1—brainstem—malignant glioma	0.000606	0.00873	CbGeAlD
Regorafenib—MAPK11—cerebellum—malignant glioma	0.000602	0.00866	CbGeAlD
Regorafenib—FLT1—retina—malignant glioma	0.000588	0.00847	CbGeAlD
Regorafenib—FGFR2—telencephalon—malignant glioma	0.000584	0.0084	CbGeAlD
Regorafenib—BRAF—midbrain—malignant glioma	0.00058	0.00835	CbGeAlD
Regorafenib—Hyponatraemia—Carmustine—malignant glioma	0.000576	0.0165	CcSEcCtD
Regorafenib—KDR—embryo—malignant glioma	0.000563	0.0081	CbGeAlD
Regorafenib—TEK—telencephalon—malignant glioma	0.00056	0.00806	CbGeAlD
Regorafenib—FLT1—telencephalon—malignant glioma	0.000541	0.00779	CbGeAlD
Regorafenib—FGFR1—medulla oblongata—malignant glioma	0.00054	0.00777	CbGeAlD
Regorafenib—RAF1—telencephalon—malignant glioma	0.000538	0.00774	CbGeAlD
Regorafenib—Hypokalaemia—Carmustine—malignant glioma	0.000522	0.0149	CcSEcCtD
Regorafenib—DDR2—brain—malignant glioma	0.000516	0.00742	CbGeAlD
Regorafenib—Dry skin—Temozolomide—malignant glioma	0.000508	0.0145	CcSEcCtD
Regorafenib—PDGFRA—telencephalon—malignant glioma	0.000507	0.0073	CbGeAlD
Regorafenib—Hypokalaemia—Temozolomide—malignant glioma	0.000505	0.0144	CcSEcCtD
Regorafenib—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.000499	0.0143	CcSEcCtD
Regorafenib—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000499	0.0143	CcSEcCtD
Regorafenib—KIT—embryo—malignant glioma	0.000498	0.00718	CbGeAlD
Regorafenib—KDR—retina—malignant glioma	0.000497	0.00716	CbGeAlD
Regorafenib—FGFR1—midbrain—malignant glioma	0.000493	0.0071	CbGeAlD
Regorafenib—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.000489	0.014	CcSEcCtD
Regorafenib—MAPK11—brain—malignant glioma	0.000489	0.00704	CbGeAlD
Regorafenib—PDGFRB—embryo—malignant glioma	0.000487	0.00701	CbGeAlD
Regorafenib—RET—medulla oblongata—malignant glioma	0.000483	0.00695	CbGeAlD
Regorafenib—FGFR1—spinal cord—malignant glioma	0.000481	0.00693	CbGeAlD
Regorafenib—Neutropenia—Carmustine—malignant glioma	0.000464	0.0133	CcSEcCtD
Regorafenib—KIT—brainstem—malignant glioma	0.000457	0.00658	CbGeAlD
Regorafenib—BRAF—cerebellum—malignant glioma	0.000449	0.00646	CbGeAlD
Regorafenib—Neutropenia—Temozolomide—malignant glioma	0.000448	0.0128	CcSEcCtD
Regorafenib—RET—midbrain—malignant glioma	0.000441	0.00635	CbGeAlD
Regorafenib—TEK—medulla oblongata—malignant glioma	0.00044	0.00633	CbGeAlD
Regorafenib—ABL1—embryo—malignant glioma	0.000434	0.00625	CbGeAlD
Regorafenib—Weight decreased—Temozolomide—malignant glioma	0.000434	0.0124	CcSEcCtD
Regorafenib—Stomatitis—Carmustine—malignant glioma	0.000431	0.0123	CcSEcCtD
Regorafenib—RET—spinal cord—malignant glioma	0.000431	0.0062	CbGeAlD
Regorafenib—EPHX2—cerebellum—malignant glioma	0.000429	0.00617	CbGeAlD
Regorafenib—Infestation—Temozolomide—malignant glioma	0.000427	0.0122	CcSEcCtD
Regorafenib—Infestation NOS—Temozolomide—malignant glioma	0.000427	0.0122	CcSEcCtD
Regorafenib—FLT1—medulla oblongata—malignant glioma	0.000425	0.00612	CbGeAlD
Regorafenib—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000424	0.0121	CcSEcCtD
Regorafenib—RAF1—medulla oblongata—malignant glioma	0.000423	0.00609	CbGeAlD
Regorafenib—Sorafenib—CYP2B6—malignant glioma	0.000421	0.0747	CrCbGaD
Regorafenib—Stomatitis—Temozolomide—malignant glioma	0.000417	0.0119	CcSEcCtD
Regorafenib—FGFR2—spinal cord—malignant glioma	0.000409	0.00589	CbGeAlD
Regorafenib—KIT—telencephalon—malignant glioma	0.000405	0.00584	CbGeAlD
Regorafenib—Hepatobiliary disease—Temozolomide—malignant glioma	0.000404	0.0116	CcSEcCtD
Regorafenib—TEK—midbrain—malignant glioma	0.000402	0.00579	CbGeAlD
Regorafenib—Haemoglobin—Carmustine—malignant glioma	0.000399	0.0114	CcSEcCtD
Regorafenib—ABL1—brainstem—malignant glioma	0.000398	0.00572	CbGeAlD
Regorafenib—Haemorrhage—Carmustine—malignant glioma	0.000397	0.0114	CcSEcCtD
Regorafenib—PDGFRB—telencephalon—malignant glioma	0.000396	0.0057	CbGeAlD
Regorafenib—TEK—spinal cord—malignant glioma	0.000392	0.00565	CbGeAlD
Regorafenib—Connective tissue disorder—Carmustine—malignant glioma	0.00039	0.0112	CcSEcCtD
Regorafenib—FLT1—midbrain—malignant glioma	0.000389	0.00559	CbGeAlD
Regorafenib—RAF1—midbrain—malignant glioma	0.000386	0.00556	CbGeAlD
Regorafenib—Haemoglobin—Temozolomide—malignant glioma	0.000386	0.011	CcSEcCtD
Regorafenib—Haemorrhage—Temozolomide—malignant glioma	0.000384	0.011	CcSEcCtD
Regorafenib—ABL1—retina—malignant glioma	0.000384	0.00552	CbGeAlD
Regorafenib—FGFR1—cerebellum—malignant glioma	0.000381	0.00549	CbGeAlD
Regorafenib—FLT1—spinal cord—malignant glioma	0.000379	0.00546	CbGeAlD
Regorafenib—Urinary tract disorder—Temozolomide—malignant glioma	0.000379	0.0108	CcSEcCtD
Regorafenib—Connective tissue disorder—Temozolomide—malignant glioma	0.000377	0.0108	CcSEcCtD
Regorafenib—RAF1—spinal cord—malignant glioma	0.000377	0.00543	CbGeAlD
Regorafenib—Urethral disorder—Temozolomide—malignant glioma	0.000376	0.0108	CcSEcCtD
Regorafenib—BRAF—brain—malignant glioma	0.000364	0.00525	CbGeAlD
Regorafenib—Erythema multiforme—Temozolomide—malignant glioma	0.000363	0.0104	CcSEcCtD
Regorafenib—KDR—medulla oblongata—malignant glioma	0.000359	0.00517	CbGeAlD
Regorafenib—Cardiac disorder—Temozolomide—malignant glioma	0.000356	0.0102	CcSEcCtD
Regorafenib—PDGFRA—spinal cord—malignant glioma	0.000355	0.00511	CbGeAlD
Regorafenib—ABL1—telencephalon—malignant glioma	0.000353	0.00508	CbGeAlD
Regorafenib—Alopecia—Carmustine—malignant glioma	0.000351	0.01	CcSEcCtD
Regorafenib—RET—central nervous system—malignant glioma	0.000349	0.00503	CbGeAlD
Regorafenib—EPHX2—brain—malignant glioma	0.000348	0.00501	CbGeAlD
Regorafenib—Angiopathy—Temozolomide—malignant glioma	0.000348	0.00996	CcSEcCtD
Regorafenib—Mediastinal disorder—Temozolomide—malignant glioma	0.000346	0.0099	CcSEcCtD
Regorafenib—Malnutrition—Carmustine—malignant glioma	0.000346	0.00989	CcSEcCtD
Regorafenib—RET—cerebellum—malignant glioma	0.000341	0.00491	CbGeAlD
Regorafenib—Alopecia—Temozolomide—malignant glioma	0.000339	0.0097	CcSEcCtD
Regorafenib—Malnutrition—Temozolomide—malignant glioma	0.000334	0.00956	CcSEcCtD
Regorafenib—FGFR2—central nervous system—malignant glioma	0.000332	0.00478	CbGeAlD
Regorafenib—KDR—midbrain—malignant glioma	0.000329	0.00473	CbGeAlD
Regorafenib—EPHA2—central nervous system—malignant glioma	0.000326	0.00469	CbGeAlD
Regorafenib—FGFR2—cerebellum—malignant glioma	0.000324	0.00467	CbGeAlD
Regorafenib—Tremor—Carmustine—malignant glioma	0.000324	0.00927	CcSEcCtD
Regorafenib—KDR—spinal cord—malignant glioma	0.000321	0.00461	CbGeAlD
Regorafenib—Anaemia—Carmustine—malignant glioma	0.000319	0.00914	CcSEcCtD
Regorafenib—KIT—medulla oblongata—malignant glioma	0.000319	0.00459	CbGeAlD
Regorafenib—TEK—central nervous system—malignant glioma	0.000318	0.00458	CbGeAlD
Regorafenib—FLT4—brain—malignant glioma	0.000314	0.00452	CbGeAlD
Regorafenib—Tremor—Temozolomide—malignant glioma	0.000313	0.00896	CcSEcCtD
Regorafenib—PDGFRB—medulla oblongata—malignant glioma	0.000311	0.00448	CbGeAlD
Regorafenib—TEK—cerebellum—malignant glioma	0.000311	0.00448	CbGeAlD
Regorafenib—FGFR1—brain—malignant glioma	0.00031	0.00446	CbGeAlD
Regorafenib—Leukopenia—Carmustine—malignant glioma	0.000309	0.00885	CcSEcCtD
Regorafenib—Anaemia—Temozolomide—malignant glioma	0.000309	0.00884	CcSEcCtD
Regorafenib—FLT1—central nervous system—malignant glioma	0.000308	0.00443	CbGeAlD
Regorafenib—RAF1—central nervous system—malignant glioma	0.000306	0.0044	CbGeAlD
Regorafenib—FLT1—cerebellum—malignant glioma	0.000301	0.00433	CbGeAlD
Regorafenib—Leukopenia—Temozolomide—malignant glioma	0.000299	0.00856	CcSEcCtD
Regorafenib—RAF1—cerebellum—malignant glioma	0.000299	0.0043	CbGeAlD
Regorafenib—Hypertension—Carmustine—malignant glioma	0.000298	0.00854	CcSEcCtD
Regorafenib—KIT—midbrain—malignant glioma	0.000291	0.00419	CbGeAlD
Regorafenib—Hypertension—Temozolomide—malignant glioma	0.000288	0.00825	CcSEcCtD
Regorafenib—PDGFRA—central nervous system—malignant glioma	0.000288	0.00415	CbGeAlD
Regorafenib—PDGFRB—midbrain—malignant glioma	0.000284	0.00409	CbGeAlD
Regorafenib—KIT—spinal cord—malignant glioma	0.000284	0.00409	CbGeAlD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000282	0.00808	CcSEcCtD
Regorafenib—PDGFRA—cerebellum—malignant glioma	0.000282	0.00406	CbGeAlD
Regorafenib—Infection—Carmustine—malignant glioma	0.00028	0.00802	CcSEcCtD
Regorafenib—Dry mouth—Temozolomide—malignant glioma	0.000278	0.00796	CcSEcCtD
Regorafenib—PDGFRB—spinal cord—malignant glioma	0.000277	0.00399	CbGeAlD
Regorafenib—ABL1—medulla oblongata—malignant glioma	0.000277	0.00399	CbGeAlD
Regorafenib—RET—brain—malignant glioma	0.000277	0.00399	CbGeAlD
Regorafenib—Thrombocytopenia—Carmustine—malignant glioma	0.000276	0.0079	CcSEcCtD
Regorafenib—Infection—Temozolomide—malignant glioma	0.000271	0.00775	CcSEcCtD
Regorafenib—Nervous system disorder—Temozolomide—malignant glioma	0.000267	0.00765	CcSEcCtD
Regorafenib—Thrombocytopenia—Temozolomide—malignant glioma	0.000267	0.00764	CcSEcCtD
Regorafenib—Skin disorder—Temozolomide—malignant glioma	0.000265	0.00758	CcSEcCtD
Regorafenib—FGFR2—brain—malignant glioma	0.000263	0.00379	CbGeAlD
Regorafenib—KDR—central nervous system—malignant glioma	0.00026	0.00374	CbGeAlD
Regorafenib—EPHA2—brain—malignant glioma	0.000259	0.00373	CbGeAlD
Regorafenib—KDR—cerebellum—malignant glioma	0.000254	0.00366	CbGeAlD
Regorafenib—ABL1—midbrain—malignant glioma	0.000253	0.00365	CbGeAlD
Regorafenib—TEK—brain—malignant glioma	0.000253	0.00364	CbGeAlD
Regorafenib—ABL1—spinal cord—malignant glioma	0.000247	0.00356	CbGeAlD
Regorafenib—Decreased appetite—Carmustine—malignant glioma	0.000245	0.00702	CcSEcCtD
Regorafenib—FLT1—brain—malignant glioma	0.000244	0.00352	CbGeAlD
Regorafenib—Gastrointestinal disorder—Carmustine—malignant glioma	0.000244	0.00697	CcSEcCtD
Regorafenib—RAF1—brain—malignant glioma	0.000243	0.00349	CbGeAlD
Regorafenib—Pain—Carmustine—malignant glioma	0.000241	0.0069	CcSEcCtD
Regorafenib—Decreased appetite—Temozolomide—malignant glioma	0.000237	0.00678	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000235	0.00674	CcSEcCtD
Regorafenib—Fatigue—Temozolomide—malignant glioma	0.000235	0.00673	CcSEcCtD
Regorafenib—Pain—Temozolomide—malignant glioma	0.000233	0.00667	CcSEcCtD
Regorafenib—Gastrointestinal pain—Carmustine—malignant glioma	0.000231	0.0066	CcSEcCtD
Regorafenib—KIT—central nervous system—malignant glioma	0.00023	0.00332	CbGeAlD
Regorafenib—PDGFRA—brain—malignant glioma	0.000229	0.00329	CbGeAlD
Regorafenib—ABCB1—blood vessel—malignant glioma	0.000226	0.00326	CbGeAlD
Regorafenib—KIT—cerebellum—malignant glioma	0.000225	0.00324	CbGeAlD
Regorafenib—PDGFRB—central nervous system—malignant glioma	0.000225	0.00324	CbGeAlD
Regorafenib—Abdominal pain—Carmustine—malignant glioma	0.000223	0.00638	CcSEcCtD
Regorafenib—Body temperature increased—Carmustine—malignant glioma	0.000223	0.00638	CcSEcCtD
Regorafenib—Gastrointestinal pain—Temozolomide—malignant glioma	0.000223	0.00638	CcSEcCtD
Regorafenib—ABCG2—telencephalon—malignant glioma	0.000223	0.0032	CbGeAlD
Regorafenib—PDGFRB—cerebellum—malignant glioma	0.00022	0.00317	CbGeAlD
Regorafenib—Abdominal pain—Temozolomide—malignant glioma	0.000215	0.00617	CcSEcCtD
Regorafenib—Body temperature increased—Temozolomide—malignant glioma	0.000215	0.00617	CcSEcCtD
Regorafenib—KDR—brain—malignant glioma	0.000206	0.00297	CbGeAlD
Regorafenib—Asthenia—Carmustine—malignant glioma	0.000202	0.00579	CcSEcCtD
Regorafenib—ABL1—central nervous system—malignant glioma	0.000201	0.00289	CbGeAlD
Regorafenib—ABL1—cerebellum—malignant glioma	0.000196	0.00282	CbGeAlD
Regorafenib—Asthenia—Temozolomide—malignant glioma	0.000196	0.0056	CcSEcCtD
Regorafenib—Diarrhoea—Carmustine—malignant glioma	0.000193	0.00552	CcSEcCtD
Regorafenib—Diarrhoea—Temozolomide—malignant glioma	0.000186	0.00534	CcSEcCtD
Regorafenib—KIT—brain—malignant glioma	0.000183	0.00263	CbGeAlD
Regorafenib—Vomiting—Carmustine—malignant glioma	0.000179	0.00513	CcSEcCtD
Regorafenib—PDGFRB—brain—malignant glioma	0.000179	0.00257	CbGeAlD
Regorafenib—Rash—Carmustine—malignant glioma	0.000178	0.00509	CcSEcCtD
Regorafenib—Dermatitis—Carmustine—malignant glioma	0.000178	0.00509	CcSEcCtD
Regorafenib—Headache—Carmustine—malignant glioma	0.000177	0.00506	CcSEcCtD
Regorafenib—ABCG2—medulla oblongata—malignant glioma	0.000175	0.00252	CbGeAlD
Regorafenib—Vomiting—Temozolomide—malignant glioma	0.000173	0.00496	CcSEcCtD
Regorafenib—Rash—Temozolomide—malignant glioma	0.000172	0.00492	CcSEcCtD
Regorafenib—Dermatitis—Temozolomide—malignant glioma	0.000172	0.00491	CcSEcCtD
Regorafenib—Headache—Temozolomide—malignant glioma	0.000171	0.00489	CcSEcCtD
Regorafenib—Nausea—Carmustine—malignant glioma	0.000168	0.0048	CcSEcCtD
Regorafenib—Nausea—Temozolomide—malignant glioma	0.000162	0.00463	CcSEcCtD
Regorafenib—ABCG2—midbrain—malignant glioma	0.00016	0.0023	CbGeAlD
Regorafenib—ABL1—brain—malignant glioma	0.000159	0.00229	CbGeAlD
Regorafenib—ABCG2—spinal cord—malignant glioma	0.000156	0.00224	CbGeAlD
Regorafenib—ABCB1—embryo—malignant glioma	0.000135	0.00194	CbGeAlD
Regorafenib—ABCG2—cerebellum—malignant glioma	0.000124	0.00178	CbGeAlD
Regorafenib—ABCB1—retina—malignant glioma	0.000119	0.00172	CbGeAlD
Regorafenib—CYP2B6—central nervous system—malignant glioma	0.000117	0.00168	CbGeAlD
Regorafenib—ABCB1—telencephalon—malignant glioma	0.00011	0.00158	CbGeAlD
Regorafenib—CYP2C8—brain—malignant glioma	0.000103	0.00149	CbGeAlD
Regorafenib—ABCG2—brain—malignant glioma	0.0001	0.00145	CbGeAlD
Regorafenib—CYP2B6—brain—malignant glioma	9.26e-05	0.00133	CbGeAlD
Regorafenib—CYP3A4—central nervous system—malignant glioma	8.81e-05	0.00127	CbGeAlD
Regorafenib—ABCB1—medulla oblongata—malignant glioma	8.62e-05	0.00124	CbGeAlD
Regorafenib—ABCB1—midbrain—malignant glioma	7.88e-05	0.00113	CbGeAlD
Regorafenib—ABCB1—spinal cord—malignant glioma	7.69e-05	0.00111	CbGeAlD
Regorafenib—ABCB1—central nervous system—malignant glioma	6.24e-05	0.000898	CbGeAlD
Regorafenib—ABCB1—cerebellum—malignant glioma	6.1e-05	0.000878	CbGeAlD
Regorafenib—ABCB1—brain—malignant glioma	4.95e-05	0.000713	CbGeAlD
Regorafenib—UGT1A1—Metabolism—PTGS2—malignant glioma	1.49e-06	9.08e-06	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—PTGS2—malignant glioma	1.49e-06	9.08e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CASP3—malignant glioma	1.48e-06	9.02e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—SPHK1—malignant glioma	1.48e-06	9.02e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—IL2—malignant glioma	1.48e-06	9e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CAT—malignant glioma	1.47e-06	8.98e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CXCL8—malignant glioma	1.47e-06	8.94e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CXCL8—malignant glioma	1.46e-06	8.92e-06	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PIK3CD—malignant glioma	1.46e-06	8.92e-06	CbGpPWpGaD
Regorafenib—RAF1—Immune System—STAT3—malignant glioma	1.46e-06	8.91e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—AKT2—malignant glioma	1.46e-06	8.9e-06	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—EGFR—malignant glioma	1.46e-06	8.88e-06	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—KRAS—malignant glioma	1.46e-06	8.88e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—EGFR—malignant glioma	1.45e-06	8.86e-06	CbGpPWpGaD
Regorafenib—ABL1—Immune System—EGFR—malignant glioma	1.45e-06	8.85e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.45e-06	8.83e-06	CbGpPWpGaD
Regorafenib—FGFR1—Disease—KRAS—malignant glioma	1.45e-06	8.82e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.45e-06	8.82e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—KRAS—malignant glioma	1.44e-06	8.79e-06	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—PIK3CA—malignant glioma	1.44e-06	8.77e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—PIK3CA—malignant glioma	1.43e-06	8.75e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.43e-06	8.74e-06	CbGpPWpGaD
Regorafenib—FGFR2—Disease—PIK3CA—malignant glioma	1.42e-06	8.69e-06	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—MMP9—malignant glioma	1.42e-06	8.68e-06	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—PTEN—malignant glioma	1.41e-06	8.63e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—MDM2—malignant glioma	1.41e-06	8.59e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—KRAS—malignant glioma	1.41e-06	8.58e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—MYC—malignant glioma	1.41e-06	8.57e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—RAF1—malignant glioma	1.4e-06	8.56e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CASP3—malignant glioma	1.4e-06	8.56e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—PIK3CD—malignant glioma	1.4e-06	8.55e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—IL2—malignant glioma	1.4e-06	8.55e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CASP3—malignant glioma	1.4e-06	8.54e-06	CbGpPWpGaD
Regorafenib—KIT—Disease—PIK3CA—malignant glioma	1.4e-06	8.53e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—IL2—malignant glioma	1.4e-06	8.52e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—MMP9—malignant glioma	1.4e-06	8.52e-06	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—VEGFA—malignant glioma	1.39e-06	8.49e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—NCOR1—malignant glioma	1.39e-06	8.48e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—ERBB2—malignant glioma	1.39e-06	8.47e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—PTEN—malignant glioma	1.39e-06	8.47e-06	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—VEGFA—malignant glioma	1.38e-06	8.41e-06	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—STAT3—malignant glioma	1.38e-06	8.4e-06	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—KRAS—malignant glioma	1.38e-06	8.39e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—EGFR—malignant glioma	1.38e-06	8.39e-06	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—AKT1—malignant glioma	1.37e-06	8.37e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—KRAS—malignant glioma	1.37e-06	8.37e-06	CbGpPWpGaD
Regorafenib—ABL1—Immune System—KRAS—malignant glioma	1.37e-06	8.36e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—PIK3CB—malignant glioma	1.37e-06	8.36e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.37e-06	8.35e-06	CbGpPWpGaD
Regorafenib—MAPK11—Gene Expression—AKT1—malignant glioma	1.37e-06	8.33e-06	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—STAT3—malignant glioma	1.36e-06	8.32e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—GSTP1—malignant glioma	1.35e-06	8.24e-06	CbGpPWpGaD
Regorafenib—RAF1—Disease—STAT3—malignant glioma	1.35e-06	8.22e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—FGF2—malignant glioma	1.34e-06	8.19e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—CAV1—malignant glioma	1.34e-06	8.16e-06	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—PIK3CA—malignant glioma	1.34e-06	8.16e-06	CbGpPWpGaD
Regorafenib—FGFR1—Disease—PIK3CA—malignant glioma	1.33e-06	8.1e-06	CbGpPWpGaD
Regorafenib—RAF1—Immune System—EGFR—malignant glioma	1.33e-06	8.1e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—MMP9—malignant glioma	1.33e-06	8.09e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—PIK3CA—malignant glioma	1.32e-06	8.08e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—MMP9—malignant glioma	1.32e-06	8.07e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—PTEN—malignant glioma	1.32e-06	8.04e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—GSTP1—malignant glioma	1.32e-06	8.04e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CXCL8—malignant glioma	1.32e-06	8.03e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—PTEN—malignant glioma	1.31e-06	8.02e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CAT—malignant glioma	1.31e-06	8.01e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—KRAS—malignant glioma	1.3e-06	7.92e-06	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—PTEN—malignant glioma	1.3e-06	7.92e-06	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—PTEN—malignant glioma	1.3e-06	7.92e-06	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—TP53—malignant glioma	1.29e-06	7.89e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—PIK3CA—malignant glioma	1.29e-06	7.88e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CAT—malignant glioma	1.28e-06	7.82e-06	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—MYC—malignant glioma	1.28e-06	7.81e-06	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—VEGFA—malignant glioma	1.28e-06	7.79e-06	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PIK3CB—malignant glioma	1.27e-06	7.77e-06	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—MYC—malignant glioma	1.27e-06	7.73e-06	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—STAT3—malignant glioma	1.26e-06	7.71e-06	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—PIK3CA—malignant glioma	1.26e-06	7.71e-06	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PTGS2—malignant glioma	1.26e-06	7.7e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—PIK3CA—malignant glioma	1.26e-06	7.69e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CASP3—malignant glioma	1.26e-06	7.69e-06	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—AKT1—malignant glioma	1.26e-06	7.69e-06	CbGpPWpGaD
Regorafenib—ABL1—Immune System—PIK3CA—malignant glioma	1.26e-06	7.68e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—IL2—malignant glioma	1.26e-06	7.68e-06	CbGpPWpGaD
Regorafenib—BRAF—Disease—AKT1—malignant glioma	1.26e-06	7.66e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—MDM2—malignant glioma	1.26e-06	7.66e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—VEGFA—malignant glioma	1.25e-06	7.65e-06	CbGpPWpGaD
Regorafenib—RAF1—Immune System—KRAS—malignant glioma	1.25e-06	7.65e-06	CbGpPWpGaD
Regorafenib—RAF1—Disease—MYC—malignant glioma	1.25e-06	7.64e-06	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—EGFR—malignant glioma	1.25e-06	7.64e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.25e-06	7.62e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—STAT3—malignant glioma	1.24e-06	7.58e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—NCOR1—malignant glioma	1.24e-06	7.57e-06	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—EGFR—malignant glioma	1.24e-06	7.57e-06	CbGpPWpGaD
Regorafenib—KIT—Immune System—AKT1—malignant glioma	1.24e-06	7.55e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—ERBB2—malignant glioma	1.24e-06	7.55e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—GSTP1—malignant glioma	1.23e-06	7.51e-06	CbGpPWpGaD
Regorafenib—RAF1—Disease—EGFR—malignant glioma	1.23e-06	7.47e-06	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—TP53—malignant glioma	1.22e-06	7.46e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—PIK3CB—malignant glioma	1.22e-06	7.45e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PIK3CG—malignant glioma	1.22e-06	7.44e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—NCOR1—malignant glioma	1.21e-06	7.39e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CAT—malignant glioma	1.2e-06	7.31e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—PIK3CA—malignant glioma	1.19e-06	7.28e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—MMP9—malignant glioma	1.19e-06	7.27e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—VEGFA—malignant glioma	1.19e-06	7.26e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—VEGFA—malignant glioma	1.19e-06	7.24e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—PTEN—malignant glioma	1.18e-06	7.22e-06	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—KRAS—malignant glioma	1.18e-06	7.21e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—STAT3—malignant glioma	1.18e-06	7.19e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PPARG—malignant glioma	1.18e-06	7.18e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—STAT3—malignant glioma	1.18e-06	7.17e-06	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—MYC—malignant glioma	1.18e-06	7.17e-06	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—AKT1—malignant glioma	1.18e-06	7.17e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CXCL8—malignant glioma	1.17e-06	7.16e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—AKT1—malignant glioma	1.17e-06	7.15e-06	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—KRAS—malignant glioma	1.17e-06	7.15e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GSTT1—malignant glioma	1.17e-06	7.14e-06	CbGpPWpGaD
Regorafenib—FGFR2—Disease—AKT1—malignant glioma	1.16e-06	7.1e-06	CbGpPWpGaD
Regorafenib—RAF1—Disease—KRAS—malignant glioma	1.16e-06	7.06e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—MYC—malignant glioma	1.15e-06	7.04e-06	CbGpPWpGaD
Regorafenib—RAF1—Immune System—PIK3CA—malignant glioma	1.15e-06	7.03e-06	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—EGFR—malignant glioma	1.15e-06	7.01e-06	CbGpPWpGaD
Regorafenib—KIT—Disease—AKT1—malignant glioma	1.14e-06	6.97e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CAV1—malignant glioma	1.13e-06	6.91e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—NCOR1—malignant glioma	1.13e-06	6.9e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—EGFR—malignant glioma	1.13e-06	6.89e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CASP3—malignant glioma	1.12e-06	6.85e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—IL2—malignant glioma	1.12e-06	6.84e-06	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PTEN—malignant glioma	1.1e-06	6.72e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PTGS1—malignant glioma	1.1e-06	6.7e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—MYC—malignant glioma	1.1e-06	6.68e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—MYC—malignant glioma	1.09e-06	6.66e-06	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—AKT1—malignant glioma	1.09e-06	6.66e-06	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—PIK3CA—malignant glioma	1.09e-06	6.63e-06	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—KRAS—malignant glioma	1.09e-06	6.62e-06	CbGpPWpGaD
Regorafenib—FGFR1—Disease—AKT1—malignant glioma	1.08e-06	6.62e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.08e-06	6.6e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—AKT1—malignant glioma	1.08e-06	6.6e-06	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—PIK3CA—malignant glioma	1.08e-06	6.57e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PIK3CD—malignant glioma	1.07e-06	6.54e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—EGFR—malignant glioma	1.07e-06	6.54e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—VEGFA—malignant glioma	1.07e-06	6.53e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—EGFR—malignant glioma	1.07e-06	6.52e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—KRAS—malignant glioma	1.07e-06	6.51e-06	CbGpPWpGaD
Regorafenib—RAF1—Disease—PIK3CA—malignant glioma	1.06e-06	6.49e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—MMP9—malignant glioma	1.06e-06	6.48e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—STAT3—malignant glioma	1.06e-06	6.46e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—AKT1—malignant glioma	1.06e-06	6.44e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—PTEN—malignant glioma	1.06e-06	6.44e-06	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—TP53—malignant glioma	1.05e-06	6.41e-06	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—TP53—malignant glioma	1.04e-06	6.35e-06	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—AKT1—malignant glioma	1.03e-06	6.3e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PIK3CG—malignant glioma	1.03e-06	6.3e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—AKT1—malignant glioma	1.03e-06	6.28e-06	CbGpPWpGaD
Regorafenib—ABL1—Immune System—AKT1—malignant glioma	1.03e-06	6.28e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—BCHE—malignant glioma	1.02e-06	6.22e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—KRAS—malignant glioma	1.01e-06	6.17e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CAV1—malignant glioma	1.01e-06	6.17e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—KRAS—malignant glioma	1.01e-06	6.16e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.01e-06	6.15e-06	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—PIK3CA—malignant glioma	9.98e-07	6.09e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PPARG—malignant glioma	9.96e-07	6.08e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CAV1—malignant glioma	9.87e-07	6.02e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—MYC—malignant glioma	9.84e-07	6e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—PIK3CA—malignant glioma	9.8e-07	5.98e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—AKT1—malignant glioma	9.75e-07	5.95e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	9.66e-07	5.89e-06	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—TP53—malignant glioma	9.65e-07	5.89e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—EGFR—malignant glioma	9.63e-07	5.87e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—VEGFA—malignant glioma	9.54e-07	5.82e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—TP53—malignant glioma	9.48e-07	5.78e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—STAT3—malignant glioma	9.44e-07	5.76e-06	CbGpPWpGaD
Regorafenib—RAF1—Immune System—AKT1—malignant glioma	9.41e-07	5.74e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PIK3CB—malignant glioma	9.34e-07	5.7e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—PIK3CA—malignant glioma	9.3e-07	5.67e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—PIK3CA—malignant glioma	9.28e-07	5.66e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PTGS2—malignant glioma	9.26e-07	5.65e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CAV1—malignant glioma	9.22e-07	5.63e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PIK3CG—malignant glioma	9.21e-07	5.62e-06	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—PIK3CA—malignant glioma	9.16e-07	5.58e-06	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—PIK3CA—malignant glioma	9.16e-07	5.58e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—KRAS—malignant glioma	9.1e-07	5.55e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PIK3CD—malignant glioma	9.07e-07	5.53e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TP53—malignant glioma	9e-07	5.49e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PIK3CG—malignant glioma	8.99e-07	5.48e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TP53—malignant glioma	8.97e-07	5.47e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PPARG—malignant glioma	8.89e-07	5.42e-06	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—AKT1—malignant glioma	8.88e-07	5.41e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.81e-07	5.37e-06	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—AKT1—malignant glioma	8.8e-07	5.36e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—MYC—malignant glioma	8.77e-07	5.35e-06	CbGpPWpGaD
Regorafenib—RAF1—Disease—AKT1—malignant glioma	8.69e-07	5.3e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PPARG—malignant glioma	8.68e-07	5.29e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—EGFR—malignant glioma	8.58e-07	5.23e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PIK3CG—malignant glioma	8.4e-07	5.12e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—PIK3CA—malignant glioma	8.36e-07	5.1e-06	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—AKT1—malignant glioma	8.15e-07	4.97e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GSTP1—malignant glioma	8.12e-07	4.95e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PPARG—malignant glioma	8.11e-07	4.95e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—KRAS—malignant glioma	8.11e-07	4.94e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PIK3CD—malignant glioma	8.1e-07	4.94e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TP53—malignant glioma	8.08e-07	4.93e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PTEN—malignant glioma	8.07e-07	4.92e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—AKT1—malignant glioma	8.01e-07	4.88e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PIK3CB—malignant glioma	7.91e-07	4.82e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PIK3CD—malignant glioma	7.91e-07	4.82e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CAT—malignant glioma	7.9e-07	4.82e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PTGS2—malignant glioma	7.84e-07	4.78e-06	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PIK3CA—malignant glioma	7.77e-07	4.74e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—AKT1—malignant glioma	7.6e-07	4.63e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—AKT1—malignant glioma	7.58e-07	4.62e-06	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—AKT1—malignant glioma	7.48e-07	4.56e-06	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—AKT1—malignant glioma	7.48e-07	4.56e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—NCOR1—malignant glioma	7.46e-07	4.55e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—PIK3CA—malignant glioma	7.45e-07	4.54e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PIK3CD—malignant glioma	7.39e-07	4.5e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TP53—malignant glioma	7.21e-07	4.39e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PIK3CB—malignant glioma	7.06e-07	4.31e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PTGS2—malignant glioma	7e-07	4.27e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PIK3CB—malignant glioma	6.89e-07	4.2e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PTEN—malignant glioma	6.84e-07	4.17e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PTGS2—malignant glioma	6.83e-07	4.16e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—AKT1—malignant glioma	6.83e-07	4.16e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PIK3CB—malignant glioma	6.44e-07	3.93e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PTGS2—malignant glioma	6.38e-07	3.89e-06	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—AKT1—malignant glioma	6.35e-07	3.87e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PTEN—malignant glioma	6.1e-07	3.72e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—AKT1—malignant glioma	6.09e-07	3.71e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CAV1—malignant glioma	6.08e-07	3.71e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PTEN—malignant glioma	5.95e-07	3.63e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PIK3CA—malignant glioma	5.7e-07	3.47e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PTEN—malignant glioma	5.56e-07	3.39e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PIK3CG—malignant glioma	5.54e-07	3.38e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PPARG—malignant glioma	5.35e-07	3.26e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PIK3CD—malignant glioma	4.87e-07	2.97e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PIK3CA—malignant glioma	4.82e-07	2.94e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—AKT1—malignant glioma	4.65e-07	2.84e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PIK3CA—malignant glioma	4.3e-07	2.62e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PIK3CB—malignant glioma	4.25e-07	2.59e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PTGS2—malignant glioma	4.21e-07	2.57e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PIK3CA—malignant glioma	4.2e-07	2.56e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—AKT1—malignant glioma	3.94e-07	2.4e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PIK3CA—malignant glioma	3.92e-07	2.39e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PTEN—malignant glioma	3.67e-07	2.24e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—AKT1—malignant glioma	3.52e-07	2.14e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—AKT1—malignant glioma	3.43e-07	2.09e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—AKT1—malignant glioma	3.21e-07	1.96e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.59e-07	1.58e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—AKT1—malignant glioma	2.11e-07	1.29e-06	CbGpPWpGaD
